Loading...
Transfer to the clinic: refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactors
The production of in vitro–derived platelets has great potential for transfusion medicine. Here, we build on our experience in the forward programming (FoP) of human pluripotent stem cells (hPSCs) to megakaryocytes (MKs) and address several aspects of the complex challenges to bring this technology...
Na minha lista:
| Udgivet i: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8045491/ https://ncbi.nlm.nih.gov/pubmed/33843988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003236 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|